(19)
(11) EP 1 155 030 A1

(12)

(43) Date of publication:
21.11.2001 Bulletin 2001/47

(21) Application number: 00911981.9

(22) Date of filing: 25.02.2000
(51) International Patent Classification (IPC)7: C07K 1/00, C07K 14/00, C07K 17/00, A21C 3/06, A21C 3/08, B28B 11/08, B28B 21/48, B28B 21/98, B29C 53/00, B29C 53/14, C12N 5/00, C12N 5/02
(86) International application number:
PCT/US0004/838
(87) International publication number:
WO 0050/445 (31.08.2000 Gazette 2000/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.02.1999 US 121787 P

(71) Applicant: Oklahoma Medical Research Foundation
Oklahoma CityOklahoma 73104 (US)

(72) Inventors:
  • CONAWAY, Joan, W.
    Oklahoma City, OK 73151 (US)
  • CONAWAY, Ronald, C.
    Oklahoma City, OK 73151 (US)
  • KAMURA, Takumi
    Oklahoma City, OK 73132 (US)

(74) Representative: Adams, Harvey Vaughan John et al
Mathys & Squire,100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

   


(54) NOVEL COMPONENT OF VON HIPPEL-LINDAU TUMOR SUPPRESSOR COMPLEX AND SCF UBIQUITIN LIGASE